Literature DB >> 25824046

Brusatol inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro.

Kyril Turpaev1, Nils Welsh2.   

Abstract

Brusatol is a natural terpenoid that is capable of inducing a variety of biological effects. We presently report that this substance dramatically improves beta-cell survival when exposed to pro-inflammatory cytokines (IL-1β and IFNγ) in vitro. This was observed in insulin producing rat (RIN-5AH), mouse (βTC6) and human (EndoC-βH1) beta-cell lines. Brusatol prevented beta-cell oxidative stress in response to cytokines and counteracted induction of iNOS on the protein level. Brusatol, however, block neither the cytokine-induced increase of iNOS mRNA, nor NF-κB activation, suggesting that inhibition of iNOS protein expression relies on posttranscriptional mechanism. This indicates that brusatol acts via a novel protective pathway, which may represent a more promising way of improving beta-cell function and survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta-cells; Brusatol; Cytokines; Oxidative stress; iNOS

Mesh:

Substances:

Year:  2015        PMID: 25824046     DOI: 10.1016/j.bbrc.2015.03.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  EndoC-βH1 cells display increased sensitivity to sodium palmitate when cultured in DMEM/F12 medium.

Authors:  Camilla Krizhanovskii; Hjalti Kristinsson; Andris Elksnis; Xuan Wang; Hamid Gavali; Peter Bergsten; Raphael Scharfmann; Nils Welsh
Journal:  Islets       Date:  2017-02-28       Impact factor: 2.694

2.  Eurycomalactone Inhibits Expression of Endothelial Adhesion Molecules at a Post-Transcriptional Level.

Authors:  Clemens Malainer; Daniel Schachner; Enrico Sangiovanni; Atanas G Atanasov; Stefan Schwaiger; Hermann Stuppner; Elke H Heiss; Verena M Dirsch
Journal:  J Nat Prod       Date:  2017-11-17       Impact factor: 4.050

3.  Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.

Authors:  Eun-Taex Oh; Chan Woo Kim; Ha Gyeong Kim; Jae-Seon Lee; Heon Joo Park
Journal:  Theranostics       Date:  2017-08-11       Impact factor: 11.556

4.  Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.

Authors:  Hai-Ming Chen; Zheng-Quan Lai; Hui-Jun Liao; Jian-Hui Xie; Yan-Fang Xian; Yun-Long Chen; Siu-Po Ip; Zhi-Xiu Lin; Zi-Ren Su
Journal:  Int J Mol Med       Date:  2018-01-09       Impact factor: 4.101

Review 5.  ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.

Authors:  Carole Nicco; Frédéric Batteux
Journal:  Molecules       Date:  2017-12-31       Impact factor: 4.411

Review 6.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

7.  Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1.

Authors:  Zhang'an Dai; Lin Cai; Yingyu Chen; Silu Wang; Qian Zhang; Chengde Wang; Ming Tu; Zhangzhang Zhu; Qun Li; Xianghe Lu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

8.  Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice.

Authors:  Jiangtao Zhou; Lihua Tan; Jianhui Xie; Zhengquan Lai; Yanfeng Huang; Chang Qu; Dandan Luo; Zhixiu Lin; Ping Huang; Ziren Su; Youliang Xie
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.